Conference themes Explore the next generation of armed oncolytic immunotherapies in combination which have the greatest potential for clinical and commercial success.
The Armed Oncolytic Immunotherapy Summit is your opportunity to hear the most up-to-date clinical advances alongside novel therapeutic strategies to increase potency, targeting and immune cell recruitment, in the effort to turn cold tumours hot.
Speakers: Akseli Hemminki (TILT Biotherapeutics), Daniel Katzman (Unleash Immuno Oncolytics), Colin Love (Replimune), Gabriella Campadelli-Fiume (NousCom), Frank Tufaro (DNAtrix)